Catalent expands beauty and plant-based consumer health softgel capabilities

Two company sites - one in Canada, the other in Brazil - receive new softgel encapsulation lines to service local customer demand.

The expansion projects include new softgel encapsulation lines at each site, dedicated to Catalent’s proprietary Vegicaps plant-based capsule and CosmoPod twist-off capsule technologies.

The increased capacity will enable the company to support its customers in both North and Latin America to develop products for consumers seeking all-natural and plant-based vitamins, minerals and supplements, using its Vegicaps capsule; and those looking for innovative, easy-to-use, unit-dose beauty care products, through its CosmoPod technology.

“We have seen increased consumer demand for greater product choice, with sales of plant-based softgel technologies growing by more than 25% globally in recent years. Additionally, Brazil has grown to become the world’s fourth-largest market for beauty care products,” commented Dr Aris Gennadios, President, Softgel & Oral Technologies, Catalent.

Previously, Catalent's manufacturing sites in Italy and Germany supplied North and Latin Americal markets with plant-based softgel capsules.

Catalent’s 110,000-sq. ft facility in Strathroy, Ontario, and its 124,600-sq. ft facility in Sorocaba, Brazil, both offer a broad range of integrated formulation, manufacturing, and packaging services to provide full-service turnkey solutions for the pharmaceutical, consumer health, and beauty industries.